BHWM
INDP icon

Beaird Harris Wealth Management’s Indaptus Therapeutics INDP Stock Holding History

Beaird Harris Wealth Management’s Portfolio INDP Stock Details INDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-11
Closed -$636 – 616
2024
Q2 		$636 Buy
+11
New +$730 ﹤0.01% 616

Other funds holding INDP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IHL
Investment House LLC Redondo Beach, California $1.92B AUM 25.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SAM
Strategy Asset Managers Pasadena, California $609M AUM 32.56% 1-Year Est. Return
PVI
Pine Valley Investments Marlton, New Jersey $2.18B AUM 26.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VCM
Vivaldi Capital Management Chicago, Illinois $723M AUM 30.89% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Beaird Harris Wealth Management's INDP Position: Q3 2024 in Review

Beaird Harris Wealth Management sold out of Indaptus Therapeutics (INDP) in Q3 2024, closing a stake of 11 shares — an estimated $636 sold.

Beaird Harris Wealth Management first reported a position in INDP in Q2 2024 and held it in 1 quarter. The position peaked at $636 in Q2 2024. 16 funds tracked by Wall St. Rank hold INDP as of Q3 2024.

  • Beaird Harris Wealth Management reported no remaining Indaptus Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Beaird Harris Wealth Management sold 11 Indaptus Therapeutics shares in Q3 2024, an estimated $636.
  • Beaird Harris Wealth Management first reported a position in Indaptus Therapeutics in Q2 2024 and held it in 1 quarter.
  • Beaird Harris Wealth Management's Indaptus Therapeutics position peaked at $636 in Q2 2024.
  • 16 funds tracked by Wall St. Rank held Indaptus Therapeutics as of Q3 2024.

Based on Beaird Harris Wealth Management's 13F filing for Q3 2024, filed 2 Dec 2024.